Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Due to the matched pairs design, no significant differences were observable between both cohorts in terms of age, sex, visit frequency, and predefined co-diagnoses including diabetes, obesity, vitamin D deficiency, and autoimmune disorders (Table 1).Baseline characteristics of the study sample (after propensity score matching)VariableProportion amongIndividuals with IBD (%) N = 24,934Proportion among individuals without IBD (%) N = 24,934p-valueAge (Mean, SD)50.3 (18.5)50.3 (18.5)0.921Age 18 to 3019.319,10.967Age 31 to 4014.214.3Age 41 to 5017.417.3Age 51 to 6017.917.9Age > 6031.231.4Women55.655.60.907Men44.444.4Number of physician visits per year during the follow-up (Mean, SD)9.4 (8.6)9.3 (8.7)0.086Diabetes18.218.30.826Obesity9.18.90.348Vitamin D deficiency3.43.40.980Autoimmune disordersa15.515.50.921Proportions of patients given in %, unless otherwise indicatedSD standard deviationaAutoimmune disorders include rheumatoid arthritis, psoriasis, atopic dermatitis, autoimmune thyroiditis, ankylosing spondylitis, systemic lupus erythematosus, celiac disease, thrombophilia
Source: Basic characteristics of the study sample. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
Source: Article title.
This study included patients aged ≥ 18 years with an initial IBD diagnosis including Crohn’s Disease (ICD-10: K50) and ulcerative colitis (ICD-10: K51) from 1,284 general practices in Germany between January 2005 and December 2020 (index date; Fig.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
Cohort study · European Journal of Medical Research · 2024
Original publication title
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Recent data suggest a potential pathophysiological link between inflammatory bowel disease (IBD) and multiple sclerosis (MS), two immune-mediated diseases both of which can have a significant impact on patients' quality of life. In the present manuscript, we investigate the association between IBD and MS in a German cohort of general practice patients. These results may have important implications for the screening and management of patients with IBD, as well as for further research into the pathophysiological mechanisms underlying both disorders.
Source: BackgroundAbstract: What methods does the paper describe?
4,934 individuals with IBD (11,140 with Crohn’s disease (CD) and 13,794 with ulcerative colitis (UC)) as well as 24,934 propensity score matched individuals without IBD were identified from the Disease Analyzer database (IQVIA). A subsequent diagnosis of MS was analyzed as a function of IBD using Cox regression models.
Source: MethodsAbstract: Results
After 10 years of follow-up, 0.9% and 0.7% of CD and UC patients but only 0.5% and 0.3% of matched non-IBD pairs were diagnosed with MS, respectively (pCD = 0.002 and pUC < 0.001). Both CD (HR: 2.09; 95% CI 1.28 to 3.39) and UC (HR: 2.35; 95% CI 1.47 to 3.78) were significantly associated with a subsequent MS diagnosis. Subgroup analysis revealed that the association between both CD and UC and MS was more pronounced among male patients.
Source: ResultsAbstract: Conclusion
The results of our analysis suggest a notable association between IBD and a subsequent MS diagnosis. These findings warrant further pathophysiological investigation and may have clinical implications for the screening of IBD patients in the future.
Source: ConclusionAuthors’ abstract
Background
Recent data suggest a potential pathophysiological link between inflammatory bowel disease (IBD) and multiple sclerosis (MS), two immune-mediated diseases both of which can have a significant impact on patients' quality of life. In the present manuscript, we investigate the association between IBD and MS in a German cohort of general practice patients. These results may have important implications for the screening and management of patients with IBD, as well as for further research into the pathophysiological mechanisms underlying both disorders.
Methods
4,934 individuals with IBD (11,140 with Crohn’s disease (CD) and 13,794 with ulcerative colitis (UC)) as well as 24,934 propensity score matched individuals without IBD were identified from the Disease Analyzer database (IQVIA). A subsequent diagnosis of MS was analyzed as a function of IBD using Cox regression models.
Results
After 10 years of follow-up, 0.9% and 0.7% of CD and UC patients but only 0.5% and 0.3% of matched non-IBD pairs were diagnosed with MS, respectively (pCD = 0.002 and pUC < 0.001). Both CD (HR: 2.09; 95% CI 1.28 to 3.39) and UC (HR: 2.35; 95% CI 1.47 to 3.78) were significantly associated with a subsequent MS diagnosis. Subgroup analysis revealed that the association between both CD and UC and MS was more pronounced among male patients.
Conclusion
The results of our analysis suggest a notable association between IBD and a subsequent MS diagnosis. These findings warrant further pathophysiological investigation and may have clinical implications for the screening of IBD patients in the future.
Key summary
Summarise the established knowledge on this subject
There is a growing body of evidence suggesting a potential pathophysiological link between inflammatory bowel disease (IBD) and multiple sclerosis (MS).
However, epidemiological data of large real-word cohorts on this potential association are scarce
In the present manuscript, we investigate the association between IBD and MS in a large cohort of over 24.000 outpatients in Germany.
What are the significant and/or new findings of this study?
Within a 10-year follow-up period, the incidence of MS was significantly higher among Crohn’s disease (CD, 0.9% vs 0.5%) and ulcerative colitis (UC) patients (0.7% vs 0.3%) compared to matched non-IBD patients.
Both CD (HR: 2.09; 95% CI 1.28 to 3.39) and UC (HR: 2.35; 95% CI 1.47 to 3.78) were significantly associated with a subsequent MS diagnosis in regression analysis.
Subgroup analysis revealed that the association between both CD and UC and MS was more pronounced among male patients.
These findings warrant further pathophysiological investigation and may have clinical implications for the screening of IBD patients in the future.
Publication and source details
Original title: Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
Kaneschka Yaqubi; Karel Kostev; Isabel Klein; Sofia Schüssler; Petra May; Tom Luedde; Christoph Roderburg; Sven H. Loosen
European Journal of Medical Research · 2024
© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Heinrich-Heine-Universität Düsseldorf (3102)Open Access funding enabled and organized by Projekt DEAL.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T12:35:27.903999+00:00
DOI: 10.1186/s40001-024-01776-w · PMC10953134